Oleic Acid

Oleic Acid

SCHEMBL146091

CCCCCCCCC=CCCCCCCCC(=O)O.NCCO

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Oleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.79
▸ PPARD Q03181 5/20 0.79
▸ PPARA Q07869 5/20 0.79
▸ F7 P08709 5/20 0.79
▸ F3 P13726 5/20 0.79
▸ TERT O14746 3/20 0.79
▸ PTPN1 P18031 3/20 0.79
▸ HSD17B10 Q99714 3/20 0.79
▸ FABP4 P15090 3/20 0.79
▸ TOP1 P11387 3/20 0.79
▸ MAPT P10636 2/20 0.79
▸ BLM P54132 2/20 0.79
▸ LMNA P02545 2/20 0.79
▸ ALOX15 P16050 2/20 0.79
▸ DUSP3 P51452 2/20 0.79
▸ CYP19A1 P11511 2/20 0.79
▸ PTGS1 P23219 2/20 0.79
▸ NR4A2 P43354 2/20 0.79
▸ SIRT6 Q8N6T7 2/20 0.79
▸ PTPN7 P35236 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleic Acid SCHEMBL146090 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL2417845 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Erucic Acid SCHEMBL27847037 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Elaidic Acid SCHEMBL21522133 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL1635026 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Palmitoleic Acid SCHEMBL28638757 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL28084566 0.95 PPARG (0.72) PPARGPPARDPPARAF7F3
Linoleic Acid SCHEMBL5874649 0.95 PPARG (0.81) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL1412017 0.93 PPARG (0.74) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL2227151 0.93 PPARG (0.85) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121021045-B Mixed fiber regenerated asphalt mixture and preparation and application thereof 中交四航局第一工程有限公司 2026-05-19 — — CN claimed
US-12617953-B2 Paint remover having reduced flammability W.M. BARR & COMPANY, INC. (US) 2026-05-05 — — US claimed
US-12509597-B2 Paint remover having reduced flammability W.M. BARR & COMPANY, INC. (US) 2025-12-30 — — US claimed
EP-4635536-A1 PUNCTURE EXTENSION DEVICE Clinicas Dr. Juan Cabrera, S.L. (ES) 2025-10-22 — — EP claimed
CN-119931760-A Water-based antirust cooling liquid and production process thereof 江苏苏堉电子材料有限公司 2025-05-06 — — CN claimed
WO-2025018955-A1 SKIN CARE PRODUCT WITH PAPER INGREDIENT MADE FROM VISCOSE AND WITH COLLAGEN ADDITIVE ECZACIBASI TUKETIM URUNLERI SANAYI VE TICARET ANONIM SIRKETI (TR) 2025-01-23 — — WO claimed
US-20240282425-A1 AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS LOW GORDON KEITH (US) 2024-08-22 — — US claimed
EP-4388070-A1 WATER-SOLUBLE FILMS AND METHODS OF USE Nohbo, Inc. (US) 2024-06-26 — — EP claimed
CN-118139961-A Water-soluble films and methods of use 诺赫博股份有限公司 2024-06-04 — — CN claimed
CN-115216281-B Reversible drilling fluid and preparation method and application thereof 西南石油大学 2024-03-01 — — CN claimed
EP-1610773-A2 USE OF COMPOUNDS FOR THE PREVENTION OF DRUG-INDUCED CELL TOXICITY Recepticon ApS (DK) 2006-01-04 — — EP claimed
US-RE38919-E1 Injectable microfoam containing a sclerosing agent BTG INTERNATIONAL LIMITED (GB) 2005-12-13 — — US claimed
WO-2005115484-A1 USE IN THE MEDICAL, DIAGNOSTIC AND PHLEBOLOGICAL FIELD OF A MIXTURE OF STERILE AND PHYSIOLOGICALLY ACCEPTABLE GASES TESSARI LORENZO (IT) 2005-12-08 — — WO claimed
CN-1678534-A Synergistic biocidal mixtures HERCULES INC (US) 2005-10-05 — — CN claimed
WO-2004084876-A2 USE OF COMPOUNDS FOR THE PREVENTION OF DRUG-INDUCED CELL TOXICITY RECEPTICON APS (DK) 2004-10-07 — — WO claimed
EP-0656203-B1 INJECTABLE MICROFOAM CONTAINING A SCLEROSING AGENT BTG INT LTD (GB) 1999-05-06 — — EP claimed
US-5676962-A TREATING ARTERIOSCLEROSIS OR ATHEROSCLEROSIS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1997-10-14 — — US claimed
US-5456693-A Embolization plugs for blood vessels VITAPHORE CORPORATION (US) 1995-10-10 — — US claimed
EP-0656203-A1 INJECTABLE MICROFOAM CONTAINING A SCLEROSING AGENT Cabrera Garrido, Juan (ES) 1995-06-07 — — EP claimed
WO-1994006460-A1 EMBOLIZATION PLUGS FOR BLOOD VESSELS VITAPHORE CORPORATION (US) 1994-03-31 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617953-B2 Paint remover having reduced flammability FAAH, FAAH2, SMURF1 PPARG 814/4885PPARD 529/4885PPARA 963/4885
US-12509597-B2 Paint remover having reduced flammability TRPM8, DSP, TRPM2 PPARG 2078/4885PPARD 1749/4885PPARA 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback